Avita Medical Inc.

RCEL Healthcare Medical Devices

Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

13.04 0.37 −2.76%
Market cap
$333.1M
P/E
0.0×
Fwd P/E
−3.6×
Dividend yield
—
F-score
3/9
Altman Z
−11.96
Beneish M
−4.09
Dividend safety
n/a
Jun '19 Dec '19 Jun '20 Dec '20 Jun '21 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — — — — 2 3 3
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.00 0.00 0.00 1.12 0.87 1.07 0.23 0.34 0.26 0.07
Altman Z-Score
42.97 1,404.38 (1.94) 16.65 (0.43) 13.90 (2.98) (3.15) (7.16) (11.96)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(12.52) (23.16) 2.05 (2.12) 11.12 9.47 1.17 (4.60) (16.38) (32.20)
Beneish M-Score
— — — — — — 0.20 (3.01) (2.03) (4.09)
P/Operating CF
0.00 (9.98) (5.24) (3.54) (6.38) 1.96 (2.35) (1.58) (2.05) (0.88)
P/B ratio
0.00 0.50 0.43 0.34 0.22 0.14 0.10 0.35 3.68 0.00
Price to Tangible BV
0.00 0.50 0.43 0.34 0.22 0.14 0.10 0.35 0.00 0.00
EV/Sales
0.00 0.00 0.00 (2.11) (2.85) (4.98) (2.04) (0.62) 0.37 0.99
EV/EBITDA
0.00 0.00 0.00 1.16 5.36 4.95 2.70 0.93 0.00 0.00
EV/Operating CF
0.45 2.44 3.33 2.82 26.22 12.64 3.69 0.82 (0.49) (2.28)
EV/FCF
0.43 2.34 3.29 2.64 22.23 12.34 3.57 0.79 (0.41) (2.15)
Quick Ratio
5.09 5.09 9.89 9.90 16.01 16.08 7.83 7.33 2.36 0.44
Current Ratio
5.50 5.50 10.17 10.17 16.42 16.42 8.18 7.88 2.83 0.57
Net Debt/EBITDA
0.83 0.65 1.78 1.56 4.30 4.03 3.01 1.47 (0.11) (0.60)
Debt/Assets
0.15% 0.15% 0.00% 2.98% 0.00% 1.26% 0.93% 35.66% 53.00% 76.22%
Debt/Equity
0.00 0.00 0.00 0.03 0.00 0.01 0.01 0.81 9.39 (2.58)
Asset Turnover
0.25 0.21 0.26 0.17 0.28 0.23 0.31 0.48 0.67 1.05
Operating CF/Net income
0.79 0.78 0.54 0.54 0.97 0.97 0.72 1.07 0.79 0.64
Capex/Depreciation
(4.77) 0.00 (1.82) 0.00 (1.64) (0.09) (0.92) (2.19) (8.14) (0.70)
Interest Coverage
(920.36) (192.77) (1,272.52) (2,824.55) (1,205.59) (3,364.12) (1,663.31) (29.90) (10.53) (8.71)
ROE
(138.34%) (117.92%) (90.09%) (58.05%) (28.27%) (22.98%) (26.61%) (52.89%) (230.96%) 799.72%
ROA
(114.36%) (96.61%) (77.66%) (50.97%) (25.57%) (21.18%) (23.83%) (33.71%) (64.64%) (71.40%)
ROIC
(1,478.09%) 0.00% 0.00% 0.00% (352.10%) (142.98%) (263.35%) 0.00% (324.79%) (334.18%)
Return on Tangible Assets
(114.83%) (118.91%) (58.34%) (56.50%) (23.04%) (22.74%) (34.20%) (38.17%) (131.98%) 261.83%
Average Days of Receivables
141.17 138.52 62.24 64.16 92.44 98.43 46.80 56.01 66.95 46.31
Research and Development Expense of Revenue
186.39% 186.39% 64.25% 59.32% 50.69% 50.69% 40.26% 41.52% 31.69% 29.10%
Selling, General and Administrative Expense of Revenue
463.54% 462.84% 341.66% 346.59% 126.78% 126.78% 131.44% 130.88% 142.24% 112.43%
Intangible Assets out of Total Assets
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.10
Share Based Compensation of Revenue
35.31% 0.00% 115.59% 0.00% 19.38% 12.27% 20.33% 16.72% 21.01% 13.29%
Graham Net Nets
0.00 1.90 2.20 2.77 4.37 5.41 9.17 2.41 (1.10) (7.81)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 96.85
Earnings Yield
(18.40%) (12.64%) (21.84%) (149.45%) (91.83%) (118.44%) (330.73%) (205.63%) (373.39%) (1,011.00%)
Free Cash Flow Yield
0.00% (40.73%) (39.88%) (71.08%) (14.69%) (37.74%) (244.34%) (229.89%) (352.21%) (687.12%)
Revenue per Share
0.43 0.02 14.05 0.70 25.78 1.29 27.54 39.58 49.65 51.41
Operating CF per Share
(1.55) (0.08) (22.41) (1.12) (22.85) (1.14) (15.27) (30.00) (37.82) (22.39)
Capex per Share
(0.10) 0.00 (0.83) 0.00 (1.04) (0.01) (0.42) (1.09) (7.09) (1.18)
Free Cash Flow per Share
(1.65) (0.08) (23.25) (1.12) (23.88) (1.15) (15.69) (31.09) (44.91) (23.57)
Cash per Share
1.64 0.08 72.75 3.64 97.86 4.89 63.47 70.29 27.73 13.05
Shareholders Equity per Share
1.71 0.08 71.33 3.57 102.02 5.10 67.79 38.72 3.48 (11.95)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.71 0.08 71.33 3.57 102.02 5.10 67.79 38.72 3.48 (11.95)
Free Cash Flow
(20.94) (19.66) (23.59) (22.75) (27.07) (26.03) (19.61) (39.39) (58.11) (32.83)
Working Capital
20.24 19.86 70.68 70.68 113.94 113.94 76.77 90.81 36.84 (27.19)
Capital Expenditures
(1.28) (1.28) (0.85) (0.85) (1.17) (0.13) (0.52) (1.38) (9.17) (1.64)
Net Current Asset Value
20.20 19.39 68.33 68.33 111.48 111.48 73.93 41.42 (18.21) (37.55)
EV/EBIT
0.00 0.00 0.00 0.86 3.14 4.83 2.64 0.91 0.00 0.00
Capex to Sales
0.23 0.00 0.06 0.00 0.04 0.00 0.02 0.03 0.14 0.02
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.20 0.21 0.34 0.26 0.49 0.49 0.47 0.34 0.11 0.27
Cash ROIC
(49.26%) (47.62%) (16.13%) (15.30%) (11.95%) (11.41%) (11.89%) (22.14%) (70.33%) (73.76%)
Accounts Receivable Turnover
1.79 2.61 6.31 5.78 5.90 3.82 5.60 8.28 6.60 6.86
Accounts Payable Turnover
0.57 0.54 1.24 0.69 1.60 1.91 1.97 2.29 1.80 1.68
Inventory Turnover
1.51 1.62 3.18 2.64 4.29 3.61 3.20 2.02 1.41 1.80
Average Days of Payables
1,211.09 143.27 531.97 531.97 191.43 191.43 181.38 177.95 252.62 255.59
Days of Inventory on Hand
227.39 223.14 138.12 138.12 101.05 101.05 128.39 262.54 291.75 197.59
Average Receivables
3.07 2.11 2.26 2.47 4.96 7.64 6.15 6.05 9.74 10.44
Average Payables
2.12 2.25 2.40 4.33 3.73 3.12 3.06 3.40 5.04 7.63
Average Inventory
0.81 0.75 0.93 1.13 1.39 1.65 1.89 3.86 6.43 7.10
Average Assets
21.64 26.03 54.12 82.46 103.98 125.50 111.88 104.95 95.68 68.05
Average Common Equity
17.89 21.32 46.65 72.40 94.03 115.66 100.20 66.90 26.78 (6.08)

Fold the line items

Columns are period end dates